Registry of X-linked Adrenoleukodystrophy

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

This study is a observational study conducted through recruiting X-linked adrenoleukodystrophy (X-ALD) patients, to build a comprehensive evaluation and long-term follow-up platform for X-ALD patients, and to provide a theoretical basis for the treatment and management of X-ALD patients.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 6
Maximum Age: 70
Healthy Volunteers: t
View:

⁃ X-ALD group:

• Meet the diagnostic criteria of X-ALD and supported by the results of genetic and very long chain fatty acid (VLCFA) test;

• Age: 6 - 70 years old;

• Able to communicate normally, and complete the test of scale as instructed (confirmed by the field test of scale);

• Sign the informed consent.

⁃ Carrier-control group:

⁃ Healthy people who have no significant difference in age, sex and education comparing with the X-ALD group, volunteer to participate in this study, could complete the test of scale as instructed, and meet the following criteria:

• Eligible for asymptomatic carriers in genetic tests (preference of patient's mother and close relatives);

• Age: 6 - 70 years old, able to complete the test of scale as instructed (confirmed by the field test of scale);

• No history of psychiatric diseases.

Locations
Other Locations
China
Beijing Tiantan Hospital
RECRUITING
Beijing
Contact Information
Primary
Yilong Wang, MD, PhD
yilong528@aliyun.com
0086-010-67092222
Time Frame
Start Date: 2023-07-20
Estimated Completion Date: 2028-12-01
Participants
Target number of participants: 200
Treatments
X-ALD
X-linked adrenoleukodystrophy (X-ALD) patients.
Carrier-control (CC)
Carriers of mutation in gene encoding ATP-binding cassette subfamily D member 1 (ABCD1), who have no X-linked adrenoleukodystrophy and are matched with the X-ALD group according to age, sex and education.
Sponsors
Leads: Beijing Tiantan Hospital

This content was sourced from clinicaltrials.gov